A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Citadel Advisors LLC holds 1,000 shares of PPH stock, worth $88,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,300 23.08%
Holding current value
$88,670
Previous $118,000 19.49%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$90.59 - $99.43 $5.83 Million - $6.4 Million
64,350 New
64,350 $6.12 Million
Q1 2024

May 15, 2024

BUY
$82.63 - $90.89 $334,734 - $368,195
4,051 Added 8.24%
53,227 $4.83 Million
Q4 2023

Feb 14, 2024

BUY
$74.32 - $81.37 $1.83 Million - $2.01 Million
24,656 Added 100.55%
49,176 $4 Million
Q3 2023

Nov 14, 2023

SELL
$76.26 - $83.18 $984,745 - $1.07 Million
-12,913 Reduced 34.5%
24,520 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$75.02 - $80.55 $894,238 - $960,156
11,920 Added 46.72%
37,433 $2.95 Million
Q1 2023

May 15, 2023

SELL
$73.68 - $79.63 $354,253 - $382,861
-4,808 Reduced 15.86%
25,513 $1.98 Million
Q4 2022

Feb 14, 2023

SELL
$67.31 - $79.26 $2.1 Million - $2.48 Million
-31,239 Reduced 50.75%
30,321 $2.36 Million
Q3 2022

Nov 14, 2022

BUY
$66.73 - $77.98 $4.11 Million - $4.8 Million
61,560 New
61,560 $4.14 Million
Q1 2022

May 16, 2022

SELL
$73.73 - $80.41 $1.72 Million - $1.88 Million
-23,395 Reduced 65.87%
12,120 $967,000
Q4 2021

Feb 14, 2022

SELL
$71.36 - $77.51 $963,360 - $1.05 Million
-13,500 Reduced 27.54%
35,515 $0
Q3 2021

Nov 15, 2021

SELL
$72.19 - $77.22 $1.16 Million - $1.24 Million
-16,013 Reduced 24.62%
49,015 $3.56 Million
Q2 2021

Aug 16, 2021

BUY
$67.83 - $74.97 $493,734 - $545,706
7,279 Added 12.6%
65,028 $0
Q1 2021

May 17, 2021

BUY
$66.06 - $71.06 $2.59 Million - $2.78 Million
39,171 Added 210.85%
57,749 $3.99 Million
Q4 2020

Feb 16, 2021

SELL
$58.91 - $66.91 $2.65 Million - $3.01 Million
-45,035 Reduced 70.8%
18,578 $1.24 Million
Q3 2020

Nov 16, 2020

BUY
$60.79 - $65.0 $1.56 Million - $1.67 Million
25,616 Added 67.42%
63,613 $3.96 Million
Q2 2020

Aug 14, 2020

SELL
$52.32 - $64.28 $167,267 - $205,503
-3,197 Reduced 7.76%
37,997 $2.37 Million
Q1 2020

May 15, 2020

SELL
$47.54 - $67.62 $336,345 - $478,411
-7,075 Reduced 14.66%
41,194 $2.24 Million
Q4 2019

Feb 14, 2020

SELL
$54.75 - $64.76 $44,238 - $52,326
-808 Reduced 1.65%
48,269 $3.1 Million
Q3 2019

Nov 14, 2019

SELL
$56.75 - $58.24 $720,100 - $739,007
-12,689 Reduced 20.54%
49,077 $0
Q2 2019

Aug 14, 2019

BUY
N/A
38,920 Added 170.36%
61,766 $3.62 Million
Q1 2019

May 15, 2019

SELL
N/A
-57,258 Reduced 71.48%
22,846 $0
Q4 2018

Feb 14, 2019

BUY
N/A
56,569 Added 240.36%
80,104 $0
Q3 2018

Nov 13, 2018

SELL
N/A
-25,894 Reduced 52.39%
23,535 $0
Q2 2018

Aug 10, 2018

BUY
N/A
29,951 Added 153.77%
49,429 $0
Q1 2018

May 11, 2018

BUY
N/A
1,966 Added 11.23%
19,478 $1.11 Million
Q4 2017

Feb 09, 2018

SELL
N/A
-998 Reduced 5.39%
17,512 $1.04 Million
Q3 2017

Nov 09, 2017

BUY
N/A
18,510
18,510 $1.07 Million

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.